High Content Analysis Systems Market Scope
High-Content Analysis (HCA), High-Content Imaging (HCI), and IC (image cytometry) are all terms used to describe the use of automated microscopy and image analysis in drug development and cell biology. Cellular imaging has become a widely used research technique, having applications in cell biology, chemical safety, and medication development. Previously, cellular imaging was thought to be a descriptive science that could only be done in a low-throughput setting. One of the HTI techniques is high-content screening (HCS), or automated microscope-based screening, which combines multi-parametric microscopy with the quantification of huge data sets of morphological characteristics. Over the previous decade, this method has progressed from an intriguing concept to a practical technology and finally to a helpful utility.
Attributes | Details |
---|
Study Period | 2018-2030 |
Base Year | 2023 |
Unit | Value (USD Million) |
Key Companies Profiled | GE Healthcare (United States), Danaher Corporation (United States), Thermo Fisher Scientific, Inc. (United States), PerkinElmer, Inc. (United States), Tecan Group (Switzerland), BioTek Instruments Inc. (United States) and Becton, Dickinson and Company (United States) |
CAGR | 20.3% |
The global market is highly competitive and consists of a limited number of providers who compete with each other. The intense competition, changing consumer spending patterns, demographic trends, and frequent changes in consumer preferences pose significant opportunities for market growth. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global High Content Analysis Systems market throughout the predicted period.
GE Healthcare (United States), Danaher Corporation (United States), Thermo Fisher Scientific, Inc. (United States), PerkinElmer, Inc. (United States), Tecan Group (Switzerland), BioTek Instruments Inc. (United States) and Becton, Dickinson and Company (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Yokogawa Electric Corporation (Japan) and Merck Millipore (United States).
About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.
Segmentation Overview
The study have segmented the market of Global High Content Analysis Systems market by Type , by Application (Target Identification & Validation, Toxicity Studies, Primary Screening & Secondary Screening, Compound Profiling and Others) and Region with country level break-up.
On the basis of geography, the market of High Content Analysis Systems has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
region held largest market share in the year 2023.
Market Leaders and their expansionary development strategies
On 25th January 2021 - Araceli Biosciences (Leading Advanced Biological Imaging Platform Developer) Launched Endeavor High Content Analysis Platform. The New Endeavor Revolutionises Drug Discovery by Offering High-Speed, High-Resolution Full-Well Scanning of Cell-Based Assays in A Fraction of The Time, Capturing Every Cell with Pictures 10 Times the Biology in A Fraction of The Time.
Influencing Trend:
Increasing Applications in Personalized Medicines
Market Growth Drivers:
Growth Across Pharmaceutical Industry Deriving Demand for Cost Containment and High Investment in Healthcare R&D
Challenges:
Lack of Expertise
Restraints:
High-Cost Expenses
Opportunities:
Government Initiatives and Venture Capital Investments Across Developed Regions
Key Target Audience
High Content Analysis System Providers, New Entrants and Investors, Venture Capitalists, Government Bodies, Corporate Entities, Government and Private Research Organizations and Others